SECsense Logo

Evaxion Biotech A/S: December 2024 Form 6-K & Extraordinary Meeting Notice

$EVAX
Form 6-K
Filed on: 2024-12-26
Source
Evaxion Biotech A/S: December 2024 Form 6-K & Extraordinary Meeting Notice

Here are the key insights extracted from the financial report (Form 6-K) of Evaxion Biotech A/S:

  1. Company Identification:
  • Name: Evaxion Biotech A/S
  • Address: Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark
  • Commission File Number: 001-39950
  1. Report Type:
  • This is a Form 6-K, which is used by foreign companies to report to the SEC.
  1. Filing Date:
  • The report was filed on December 26, 2024.
  1. Extraordinary General Meeting:
  • The report includes a convening notice for an Extraordinary General Meeting scheduled for January 17, 2025, at 3:00 PM CET.
  1. Exhibits Included:
  • Exhibit 99.1: Convening Notice to Shareholders for the Extraordinary General Meeting.
  • Exhibit 99.2: Proxy form for the Extraordinary General Meeting.
  1. Incorporation by Reference:
  • The report states that it will be deemed incorporated by reference in several registration statements filed under various forms (S-8, F-3, F-1) with the SEC.
  1. Signatory:
  • The report is signed by Christian Kanstrup, Chief Executive Officer of Evaxion Biotech A/S.

This report primarily serves to notify shareholders about the upcoming meeting and includes necessary documentation related to it. The incorporation by reference indicates the intent to use this filing for future SEC reporting obligations.